Genzyme's Cancer Drug IP Suit Can Proceed, Judge Says
Generic-drug maker Abon Pharmaceuticals LLC couldn't convince a New Jersey federal judge to toss Genzyme Corp. and the Southern Research Institute's patent suit over a leukemia treatment, with the court on...To view the full article, register now.
Already a subscriber? Click here to view full article